Institutions / Blue Owl Capital Holdings LP
Blue Owl Capital Holdings LP
CIK 1858703 · Institution · as of Dec 31, 2025
Portfolio value
$324.04M
Positions
80
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 80 →
| Company | Value | % of portfolio |
|---|---|---|
| enGene Therapeutics Inc. | $30.35M | 9.4% |
| Nuveen Churchill Direct Lending Corp.NCDL | $28.60M | 8.8% |
| Blue Owl Capital CorpOBDC | $26.12M | 8.1% |
| Larimar Therapeutics, Inc. | $26.00M | 8.0% |
| Cullinan Therapeutics, Inc. | $24.33M | 7.5% |
| Compass Therapeutics, Inc. | $18.62M | 5.7% |
| Holley Inc.HLLY | $17.13M | 5.3% |
| Context Therapeutics Inc. | $10.93M | 3.4% |
| CONDUENT Inc | $9.26M | 2.9% |
| Repare Therapeutics Inc | $8.95M | 2.8% |
| Civeo CorpCVEO | $8.47M | 2.6% |
| Sagimet Biosciences Inc.SGMT | $7.36M | 2.3% |
| EyePoint, Inc. | $7.17M | 2.2% |
| Procore Technologies, Inc. | $6.86M | 2.1% |
| Dell Technologies Inc. | $6.78M | 2.1% |
| KalVista Pharmaceuticals Inc | $5.81M | 1.8% |
| Maplight Therapeutics IncMPLT | $5.74M | 1.8% |
| Roivant Sciences Ltd. | $5.71M | 1.8% |
| ImageneBio, Inc.IMA | $5.68M | 1.8% |
| Immix Biopharma, Inc. | $5.16M | 1.6% |
| Ultragenyx Pharmaceutical Inc. | $4.89M | 1.5% |
| Immuneering CorpIMRX | $4.38M | 1.4% |
| Palvella Therapeutics, Inc.PVLA | $4.21M | 1.3% |
| Oric Pharmaceuticals, Inc. | $4.21M | 1.3% |
| Payoneer Global Inc. | $3.98M | 1.2% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.